Literature DB >> 11326219

Possible consequences of social drinking in the early stages of Alzheimer disease.

R Wiscott1, K Kopera-Frye, L Seifert.   

Abstract

Although research supports the idea that alcohol is not a risk factor for developing Alzheimer disease (AD), surprisingly little attention has been given to the role of social drinking in the early stages of the disorder. The current review highlights potential alcohol- and disease-related interactions on neurologic, cognitive, and behavioral functioning in individuals experiencing the early stages of AD. Understanding how alcohol interacts with AD can benefit both treatment providers (eg, interpreting clinical tests) and caregivers (eg, managing disruptive behaviors) by providing important clues to potentially reversible impairments that may negatively affect the everyday functioning of individuals with the disorder.

Entities:  

Mesh:

Year:  2001        PMID: 11326219     DOI: 10.1067/mgn.2001.115201

Source DB:  PubMed          Journal:  Geriatr Nurs        ISSN: 0197-4572            Impact factor:   2.361


  4 in total

1.  The impacts of a GO-game (Chinese chess) intervention on Alzheimer disease in a Northeast Chinese population.

Authors:  Qiao Lin; Yunpeng Cao; Jie Gao
Journal:  Front Aging Neurosci       Date:  2015-08-25       Impact factor: 5.750

2.  Alcohol consumption and mortality in patients with mild Alzheimer's disease: a prospective cohort study.

Authors:  Sine Berntsen; Jakob Kragstrup; Volkert Siersma; Gunhild Waldemar; Frans Boch Waldorff
Journal:  BMJ Open       Date:  2015-12-11       Impact factor: 2.692

3.  Serum calreticulin is a negative biomarker in patients with Alzheimer's disease.

Authors:  Qiao Lin; Yunpeng Cao; Jie Gao
Journal:  Int J Mol Sci       Date:  2014-11-25       Impact factor: 5.923

4.  Decreased expression of the APOA1-APOC3-APOA4 gene cluster is associated with risk of Alzheimer's disease.

Authors:  Qiao Lin; Yunpeng Cao; Jie Gao
Journal:  Drug Des Devel Ther       Date:  2015-09-29       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.